5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)-
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)- Basic information
- Product Name:
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)-
- Synonyms:
-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)-
- 7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(formylamino)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
- 7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-[[3-formylamino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
- Baumycin C2
- Baumycin C2 (Mixture of Diastereomers)
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(formylamino)-α-L-lyxo-hexopyranosyl]oxy]- (9CI)
- CAS:
- 64479-55-6
- MF:
- C28H31NO11
- MW:
- 557.55
- Mol File:
- 64479-55-6.mol
More
Less
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)- Chemical Properties
- Boiling point:
- 847.3±65.0 °C(Predicted)
- Density
- 1.55±0.1 g/cm3(Predicted)
- pka
- 7.54±0.60(Predicted)
More
Less
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)- Usage And Synthesis
Uses
Baumycin C2 is a molecule of interest in the research of Doxorubicin (23214-92-8) analogs/impurities. Doxorubicin is a chemotherapy drug commonly used to treat leukemias and Hodgkin''s lymphoma, cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma, among others.